Press & Media

IndyGeneUS Expands its Biologics & Gene Target Discovery Capabilities with SanKav Pharmaceutical (CDMO) Partnership

IndyGeneUS | March 4, 2024

Innovative biotech company IndyGeneUS has announced a groundbreaking partnership with SanKav Pharmaceuticals, a leading provider of biopharmaceutical and cell & gene therapy analytics and manufacturing services. This strategic collaboration will significantly enhance IndyGeneUS’s drug discovery capabilities and pave the way for the development of advanced therapeutics to address health disparities impacting African and Hispanic diaspora populations.

Grand Opening

SanKav Pharmaceuticals | January 9, 2023

On January 9, 2023, SanKav Pharmaceuticals officially opened its doors to start offering services in R&D, manufacturing, packaging, and analytical testing services.

The program of the day included statements from CEO and founder Sanjeev K. Gupta, guests of honor Assemblywomen Aura K. Dunn, Washington Township Mayor Matthew Murello, and Morris County Commissioner Director John Krickus. Attendees all received a site tour and finished the day with a presentation on Essential Medicines & Biotech.

Watch Video

Biopharma resilience: CDMOs secure supply chain management

Cytiva | November 16, 2022

Learn how SanKav Pharmaceuticals delivers medicine to market through available components, resources and raw materials that support on-time production lines and biomanufacturing processes.

20 Newburgh Road
Washington Township NJ 07840
(Morris County)
201.312.8591

© 2025 by SanKav Pharmaceuticals LLC. All Rights Reserved. Designed by Tanya Gupta.

envelopephone linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram